Danielle M McMaster

Title: The Innovative Contributions of Danielle M McMaster

Introduction

Danielle M McMaster is a notable inventor based in Boothwyn, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective glucocorticoid receptor ligands. With a total of 2 patents, her work is aimed at addressing various autoimmune and inflammatory diseases.

Latest Patents

Danielle's latest patents include innovative compounds such as hexahydrocyclopentyl[f]imidazole carboxamides and derivatives. These compounds are designed as selective glucocorticoid receptor ligands, which are useful for treating a variety of autoimmune and inflammatory diseases or conditions. Additionally, she has developed hexahydrocyclopentyl[f]indazole sulfonamides and derivatives, which also serve as selective glucocorticoid receptor modulators, further contributing to pharmaceutical compositions and methods of use.

Career Highlights

Danielle is currently associated with Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments that can improve the quality of life for patients suffering from chronic conditions.

Collaborations

Danielle has collaborated with esteemed colleagues such as William P Dankulich and Robert S Meissner. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.

Conclusion

Danielle M McMaster's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in treating autoimmune and inflammatory diseases.